120 related articles for article (PubMed ID: 16856496)
1. Interaction between Mnk2 and CBC(VHL) ubiquitin ligase E3 complex.
Wang P; Wang X; Wang F; Cai T; Luo Y
Sci China C Life Sci; 2006 Jun; 49(3):265-73. PubMed ID: 16856496
[TBL] [Abstract][Full Text] [Related]
2. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
Kamura T; Maenaka K; Kotoshiba S; Matsumoto M; Kohda D; Conaway RC; Conaway JW; Nakayama KI
Genes Dev; 2004 Dec; 18(24):3055-65. PubMed ID: 15601820
[TBL] [Abstract][Full Text] [Related]
3. A molecular basis for stabilization of the von Hippel-Lindau (VHL) tumor suppressor protein by components of the VHL ubiquitin ligase.
Kamura T; Brower CS; Conaway RC; Conaway JW
J Biol Chem; 2002 Aug; 277(33):30388-93. PubMed ID: 12048197
[TBL] [Abstract][Full Text] [Related]
4. Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex.
Cardote TAF; Gadd MS; Ciulli A
Structure; 2017 Jun; 25(6):901-911.e3. PubMed ID: 28591624
[TBL] [Abstract][Full Text] [Related]
5. The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells.
Scheper GC; Morrice NA; Kleijn M; Proud CG
Mol Cell Biol; 2001 Feb; 21(3):743-54. PubMed ID: 11154262
[TBL] [Abstract][Full Text] [Related]
6. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
[TBL] [Abstract][Full Text] [Related]
7. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
[TBL] [Abstract][Full Text] [Related]
8. Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL).
Heir P; Ohh M
Methods Mol Biol; 2016; 1458():87-94. PubMed ID: 27581016
[TBL] [Abstract][Full Text] [Related]
9. The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2.
Kamura T; Conrad MN; Yan Q; Conaway RC; Conaway JW
Genes Dev; 1999 Nov; 13(22):2928-33. PubMed ID: 10579999
[TBL] [Abstract][Full Text] [Related]
10. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS.
Uchida T; Tamaki Y; Ayaki T; Shodai A; Kaji S; Morimura T; Banno Y; Nishitsuji K; Sakashita N; Maki T; Yamashita H; Ito H; Takahashi R; Urushitani M
Sci Rep; 2016 Jan; 6():19118. PubMed ID: 26751167
[TBL] [Abstract][Full Text] [Related]
11. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
12. DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase.
Heir P; Sufan RI; Greer SN; Poon BP; Lee JE; Ohh M
Mol Cell Biol; 2013 Apr; 33(8):1621-31. PubMed ID: 23401859
[TBL] [Abstract][Full Text] [Related]
13. The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer.
Liu X; Zurlo G; Zhang Q
Adv Exp Med Biol; 2020; 1217():173-186. PubMed ID: 31898228
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal signaling between mTORC1 and MNK2 controls cell growth and oncogenesis.
Xie J; Shen K; Jones AT; Yang J; Tee AR; Shen MH; Yu M; Irani S; Wong D; Merrett JE; Lenchine RV; De Poi S; Jensen KB; Trim PJ; Snel MF; Kamei M; Martin SK; Fitter S; Tian S; Wang X; Butler LM; Zannettino ACW; Proud CG
Cell Mol Life Sci; 2021 Jan; 78(1):249-270. PubMed ID: 32170339
[TBL] [Abstract][Full Text] [Related]
15. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.
Iwai K; Yamanaka K; Kamura T; Minato N; Conaway RC; Conaway JW; Klausner RD; Pause A
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12436-41. PubMed ID: 10535940
[TBL] [Abstract][Full Text] [Related]
16. Atlas on substrate recognition subunits of CRL2 E3 ligases.
Wang S; Xia W; Qiu M; Wang X; Jiang F; Yin R; Xu L
Oncotarget; 2016 Jul; 7(29):46707-46716. PubMed ID: 27107416
[TBL] [Abstract][Full Text] [Related]
17. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.
Cai QL; Knight JS; Verma SC; Zald P; Robertson ES
PLoS Pathog; 2006 Oct; 2(10):e116. PubMed ID: 17069461
[TBL] [Abstract][Full Text] [Related]
18. Proteomic dissection of the von Hippel-Lindau (VHL) interactome.
Lai Y; Song M; Hakala K; Weintraub ST; Shiio Y
J Proteome Res; 2011 Nov; 10(11):5175-82. PubMed ID: 21942715
[TBL] [Abstract][Full Text] [Related]
19. No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer.
Huang KT; Dobrovic A; Fox SB
Breast Cancer Res Treat; 2010 Dec; 124(3):853-6. PubMed ID: 20680678
[TBL] [Abstract][Full Text] [Related]
20. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase.
Kamura T; Koepp DM; Conrad MN; Skowyra D; Moreland RJ; Iliopoulos O; Lane WS; Kaelin WG; Elledge SJ; Conaway RC; Harper JW; Conaway JW
Science; 1999 Apr; 284(5414):657-61. PubMed ID: 10213691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
